Nothing Special   »   [go: up one dir, main page]

WO2004037210A3 - Functional mri agents for cancer imaging - Google Patents

Functional mri agents for cancer imaging Download PDF

Info

Publication number
WO2004037210A3
WO2004037210A3 PCT/US2003/034044 US0334044W WO2004037210A3 WO 2004037210 A3 WO2004037210 A3 WO 2004037210A3 US 0334044 W US0334044 W US 0334044W WO 2004037210 A3 WO2004037210 A3 WO 2004037210A3
Authority
WO
WIPO (PCT)
Prior art keywords
functional mri
cancer imaging
mri agents
imaging
cancer
Prior art date
Application number
PCT/US2003/034044
Other languages
French (fr)
Other versions
WO2004037210A2 (en
Inventor
Thomas J Meade
Mattew J Allen
Douglas A Bakan
Original Assignee
Res Corp Technologies Inc
Thomas J Meade
Mattew J Allen
Douglas A Bakan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc, Thomas J Meade, Mattew J Allen, Douglas A Bakan filed Critical Res Corp Technologies Inc
Priority to EP03777915A priority Critical patent/EP1558137A2/en
Priority to AU2003286705A priority patent/AU2003286705A1/en
Publication of WO2004037210A2 publication Critical patent/WO2004037210A2/en
Publication of WO2004037210A3 publication Critical patent/WO2004037210A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/14—Peptides, e.g. proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

The invention relates to novel magnetic resonance imaging contrast agents for imaging cancer.
PCT/US2003/034044 2002-10-24 2003-10-24 Functional mri agents for cancer imaging WO2004037210A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP03777915A EP1558137A2 (en) 2002-10-24 2003-10-24 Functional mri agents for cancer imaging
AU2003286705A AU2003286705A1 (en) 2002-10-24 2003-10-24 Functional mri agents for cancer imaging

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42147002P 2002-10-24 2002-10-24
US60/421,470 2002-10-24
US71585902A 2002-11-17 2002-11-17

Publications (2)

Publication Number Publication Date
WO2004037210A2 WO2004037210A2 (en) 2004-05-06
WO2004037210A3 true WO2004037210A3 (en) 2004-07-08

Family

ID=34312085

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2003/034044 WO2004037210A2 (en) 2002-10-24 2003-10-24 Functional mri agents for cancer imaging

Country Status (3)

Country Link
EP (1) EP1558137A2 (en)
AU (1) AU2003286705A1 (en)
WO (1) WO2004037210A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9138484B2 (en) 2007-06-25 2015-09-22 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
US9505747B2 (en) 2012-03-29 2016-11-29 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
US9550734B2 (en) 2004-07-23 2017-01-24 Endocyte, Inc. Bivalent linkers and conjugates thereof
US9555139B2 (en) 2007-03-14 2017-01-31 Endocyte, Inc. Binding ligand linked drug delivery conjugates of tubulysins

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
WO2013126797A1 (en) 2012-02-24 2013-08-29 Purdue Research Foundation Cholecystokinin b receptor targeting for imaging and therapy
AU2013331440A1 (en) 2012-10-16 2015-04-30 Endocyte, Inc. Drug delivery conjugates containing unnatural amino acids and methods for using

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6120768A (en) * 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6120768A (en) * 1993-05-17 2000-09-19 Immunomedics, Inc. Dota-biotin derivatives

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9550734B2 (en) 2004-07-23 2017-01-24 Endocyte, Inc. Bivalent linkers and conjugates thereof
US9555139B2 (en) 2007-03-14 2017-01-31 Endocyte, Inc. Binding ligand linked drug delivery conjugates of tubulysins
US9138484B2 (en) 2007-06-25 2015-09-22 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
US9505747B2 (en) 2012-03-29 2016-11-29 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof

Also Published As

Publication number Publication date
WO2004037210A2 (en) 2004-05-06
AU2003286705A8 (en) 2004-05-13
AU2003286705A1 (en) 2004-05-13
EP1558137A2 (en) 2005-08-03

Similar Documents

Publication Publication Date Title
WO2001082976A3 (en) Functional mri agents for cancer imaging
AU2002239655A1 (en) Contrast enhancement agent for magnetic resonance imaging
AU2003225287A1 (en) Magnetic resonance imaging
AU2003217553A1 (en) Magnetic resonance imaging capable catheter assembly
EP1825808A4 (en) Magnetic resonance imaging system
EP1629773B8 (en) Magnetic resonance diagnostic apparatus
AU2003224377A1 (en) Prior-information-enhanced dynamic magnetic resonance imaging
AU2002348240A1 (en) Medical devices visible under magnetic resonance imaging
GB0117187D0 (en) Magnetic resonance imaging
AU2003295183A1 (en) Magnetic resonance compatible stent
DE50204163D1 (en) Mammography supplement for MR elastography
AU2003234310A1 (en) Variable k-space-density parallel magnetic resonance imaging
AU2002360295A1 (en) Scoutless whole-body imaging with fast positioning
AU2002256312A1 (en) Combining unfold with parallel magnetic resonance imaging
AU2003234183A1 (en) Novel macrocyclic activatible magnetic resonance imaging contrast agents
AU2002364728A1 (en) Method for mr/nmr imaging
GB0109790D0 (en) Magnetic resonance imaging
AU2003215859A1 (en) T1-weighted multiecho magnetic resonance imaging
GB0121744D0 (en) Magnetic resonance imaging
WO2004037210A3 (en) Functional mri agents for cancer imaging
AU2003233874A1 (en) Magnetic resonance imaging receive circuit
GB0109791D0 (en) Magnetic resonance imaging
AU2002303271A1 (en) Novel functional agents for magnetic resonance imaging
AU2003224375A1 (en) Magnetic resonance imaging
AU2003230110A1 (en) Magnetic resonance imaging method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003777915

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2003777915

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP